Our earlier work demonstrated that the antiviral drug ribavirin cooperated with chemotherapy and immunotherapy in RCC, via inhibition of eukaryotic translation initiation factor 4E [25]. This evidence concerns the gene EIF4E and renal cell carcinoma.